Todas las investigaciones
ReclutamientoFASE1, FASE2INTERVENCIONISTA

A Study to Evaluate BMS-986470 in Healthy Volunteers and Participants With Sickle Cell Disease

This research study is looking at a new medication called BMS-986470. It's being tested in two groups: healthy volunteers and people who have sickle cell disease. For all participants, the main goals are to make sure the medicine is safe and well-tolerated, and to understand how it behaves in the body. For those with sickle cell disease, the study also aims to see if this new medicine could help improve symptoms, such as painful crises. The study is in its early stages (Phases 1 and 2), meaning it's one of the first times this medicine is being given to people.

De un vistazo

Estado
Reclutamiento
Fase
FASE1, FASE2
Patrocinador
Bristol-Myers Squibb
Objetivo de inscripción
224
Inicio
17 Jul 2024
Estimación de finalización
16 Nov 2027

¿De qué trata este estudio?

Imagine you or someone you know lives with sickle cell disease (SCD), a condition where red blood cells are shaped like crescent moons instead of round discs. These oddly shaped cells can block tiny blood vessels, leading to severe pain, called a vaso-occlusive crisis (VOC), and other health problems. Researchers are always looking for new ways to help manage this condition and improve the lives of people with SCD.

This study, called "A Study to Evaluate BMS-986470 in Healthy Volunteers and Participants With Sickle Cell Disease," is exploring a new medicine named BMS-986470. The study has two main parts. One part involves healthy volunteers who don't have sickle cell disease. Their involvement helps researchers understand how the new medicine works in the body and what effects it might have, before it's given to people who are unwell. The other part involves people living with sickle cell disease.

For the healthy volunteers, the focus is entirely on safety and understanding how the body handles the medicine. For people with sickle cell disease, the study will also look at whether the medicine helps reduce symptoms like painful crises. This is an early-stage study, meaning it's one of the first times this particular medicine has been given to people. The information gathered will be crucial for deciding if this medicine has potential as a future treatment for sickle cell disease.

Puntos clave

  • This study is testing a new medicine (BMS-986470) for sickle cell disease.
  • It involves both healthy volunteers and people with sickle cell disease.
  • The main goals are to check the medicine's safety, how it works, and if it helps with sickle cell symptoms.
  • This is an early-stage clinical trial (Phases 1 and 2).
  • Participation involves clinic visits, assessments, and taking the study medication or a placebo.
  • Puede retirarse del estudio en cualquier momento.

¿Quién puede ser elegible?

To join this study, you need to be at least 18 years old. There are two groups of participants: healthy volunteers and people with sickle cell disease.

If you're a healthy volunteer, you'll need to be in general good health, as confirmed by a doctor, and have a body weight that falls within a certain range. Women who are able to have children won't be able to join this group. You also shouldn't have any major medical conditions or planned surgeries.

If you have sickle cell disease, you'll need to have a confirmed diagnosis (types HbSS, HbSβ0-thal, or HbSβ+-thal) and have experienced a certain number of painful crises (at least 4 in the last year, or 2 in the last 6 months). Your general health should be good enough to take part in a study, and your blood test results, like haemoglobin and white blood cell counts, must be within specific limits. You also shouldn't have any other significant medical conditions that could make it unsafe to participate.

¿Podría este estudio ser adecuado para ti?

Responde estas preguntas rápidas para ver si puedes ser elegible. Esto es solo una guía: el equipo de investigación toma la decisión final.

  1. Are you aged 18 or older?
  2. Do you have a diagnosis of sickle cell disease (HbSS, HbSβ0-thal, or HbSβ+-thal) or are you a healthy adult?
  3. If you have sickle cell disease, have you had at least 4 painful crises in the last year, or 2 in the last 6 months?
  4. Are you generally in good health, as assessed by a doctor?
  5. Are you willing and able to attend all required study appointments?
  6. If you are a woman of childbearing potential, are you prepared to use effective contraception if required for the study?
Responde cada pregunta para ver tu resultado.

¿En qué consiste la participación?

Taking part in this study means you would likely have several visits to the study clinic. During these visits, the study team would perform various assessments. This includes physical examinations, checking your vital signs (like blood pressure and heart rate), taking blood and urine samples, and performing heart checks (ECGs). You'll be given the study medication, which could be BMS-986470, a placebo (a dummy medicine with no active ingredients), or famotidine (a common heartburn medicine used as a comparison). You won't know which one you're receiving. The study involves regular follow-up to monitor your health and how you respond to the treatment. The total duration of your participation in the study would be explained in detail by the study team.

Riesgos y beneficios potenciales

As with any medical study, there are potential benefits and potential risks to consider. A potential benefit of taking part is that you would be contributing to medical research that could help advance treatments for sickle cell disease. For those with sickle cell disease, there's also a possibility that the new medicine could help improve your symptoms, although this is not guaranteed for an early-stage study. Potential risks include side effects from the study medication, which the researchers will monitor very closely. There are also risks associated with the tests and procedures involved, such as discomfort from blood draws. You will be given full information about all known and potential risks before you decide to join. Remember, you have the right to withdraw from the study at any time, for any reason, without it affecting your usual medical care.

Locations (32)

  • University of Alabama at Birmingham
    Código postal verificado
    Birmingham, United States· Reclutamiento
  • University of California San Diego - La Jolla
    Código postal verificado
    La Jolla, Estados Unidos· Reclutamiento
  • UCSF Benioff Children's Hospital Oakland
    Código postal verificado
    Oakland, United States· Reclutamiento
  • Yale-New Haven Hospital
    Código postal verificado
    New Haven, Estados Unidos· Reclutamiento
  • Winship Cancer Institute of Emory University
    Código postal verificado
    Atlanta, Estados Unidos· Reclutamiento
  • Local Institution - 0034
    Código postal verificado
    Chicago, Estados Unidos· Aún no reclutando
  • Local Institution - 0001
    Código postal verificado
    Lenexa, United States· Activo, no reclutando
  • Local Institution - 0064
    Código postal verificado
    Baltimore, Estados Unidos· Aún no reclutando
  • Institución Local - 0024
    Código postal verificado
    Boston, Estados Unidos· Aún no reclutando
  • Boston Medical Center
    Código postal verificado
    Boston, Estados Unidos· Reclutamiento
  • Local Institution - 0030
    Código postal verificado
    San Luis, Estados Unidos· Aún no reclutando
  • Local Institution - 0033
    Código postal verificado
    Greenville, United States· Aún no reclutando

Preguntas comunes

What is sickle cell disease?

Sickle cell disease is a blood disorder where red blood cells become crescent-shaped, causing pain and other health issues.

¿Qué es un placebo?

A placebo is an inactive 'dummy' medicine that looks like the real treatment but contains no active ingredients. It helps researchers compare results.

Why are healthy volunteers included in the study?

Healthy volunteers help researchers understand how the new medicine works in the body and if it's safe before it's given to people with the disease.

Can I leave the study if I decide to?

Yes, you have the right to withdraw from the study at any time, for any reason, without it affecting your regular medical care.

What are 'Phases 1 and 2' of a study?

These are early stages of drug development. Phase 1 focuses on safety and how the medicine works in the body, while Phase 2 looks at effectiveness and dose.

Cómo obtener más información

Centro de Contacto de Ensayos Clínicos de BMS www.BMSClinicalTrials.com

Siempre hable con su médico de cabecera o especialista antes de decidir participar en un estudio.

¿Interesado en participar?

Registra tu interés

Comparte tus detalles y el equipo de investigación para "A Study to Evaluate BMS-986470 in Healthy Volunteers and Par…" se pondrá en contacto contigo si puedes ser elegible. Siempre habla con tu médico antes de aceptar participar.

Discusión

Discusión comunitaria

Impulsado por nuestro foro en community.patient.info. Por favor, sea respetuoso — esto no es un consejo médico.